Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Metabolic Associated Steatotic Liver Disease: early-phase trial registry
2 of 2 indexed Metabolic Associated Steatotic Liver Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Metabolic Associated Steatotic Liver Disease: 2 US clinical trials tracked, 2 recruiting.
Metabolic Associated Steatotic Liver Disease is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Foundation for the National Institutes of Health, running 1 of these trials.
Enrollment posture brief
Registry condition metabolic-associated-steatotic-liver-disease
OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Metabolic Associated Steatotic Liver Disease lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Metabolic Associated Steatotic Liver Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Metabolic Associated Steatotic Liver Disease is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Foundation for the National Institutes of Health
NCT07122700
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
Vanderbilt University Medical Center
NCT06113003
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Metabolic Associated Steatotic Liver Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Metabolic Associated Steatotic Liver Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Metabolic Associated Steatotic Liver Disease page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Metabolic Associated Steatotic Liver Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Foundation for the National Institutes of Health sponsors the most Metabolic Associated Steatotic Liver Disease trials on record, review their full trial history before evaluating a specific study. See Foundation for the National Institutes of Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Metabolic Associated Steatotic Liver Disease condition card totals 2 registered trials; most-linked intervention Prebiotic; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.